{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:08:59Z","timestamp":1793088539179,"version":"4.5.0"},"reference-count":276,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.disamonth.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T21:16:58Z","timestamp":1503091018000},"page":"20-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":492,"title":["A comprehensive review and update on Crohn's disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Mahesh","family":"Gajendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarshini","family":"Loganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Catinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana G.","family":"Hashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib1","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohn\u2019s disease and ulcerative colitis in the United States","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.suc.2015.07.006","article-title":"Inflammatory Bowel Disease: historical Perspective, Epidemiology, and Risk Factors","volume":"95","author":"Malik","year":"2015","journal-title":"Surg Clin N Am"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/gut.46.3.336","article-title":"Ulcerative colitis in Olmsted County, Minnesota, 1940\u20131993: incidence, prevalence, and survival","volume":"46","author":"Loftus","year":"2000","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0016-5085(98)70421-4","article-title":"Crohn\u2019s disease in Olmsted County, Minnesota, 1940\u20131993: incidence, prevalence, and survival","volume":"114","author":"Loftus","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jama.1984.03340250053024","article-title":"Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer","volume":"251","author":"Crohn","year":"1984","journal-title":"JAMA"},{"issue":"6837","key":"10.1016\/j.disamonth.2017.07.001_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.disamonth.2017.07.001_bib9","doi-asserted-by":"crossref","unstructured":"Hugot J-P, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn\u2019s disease on chromosome. 1996;16.","DOI":"10.1038\/379821a0"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00004836-198806000-00012","article-title":"Historical aspects of inflammatory bowel disease","volume":"10","author":"Kirsner","year":"1988","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02232730","article-title":"Long term therapy of ulcerative colitis with 6-mercaptopurine: a personal series","volume":"17","author":"Korelitz","year":"1972","journal-title":"Am J Dig Dis"},{"issue":"6837","key":"10.1016\/j.disamonth.2017.07.001_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.disamonth.2017.07.001_bib13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib15","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1111\/j.1572-0241.2008.02158.x","article-title":"An update on the epidemiology of inflammatory bowel disease in Asia","volume":"103","author":"Thia","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.gastro.2013.04.007","article-title":"Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn\u2019s and colitis epidemiology study","volume":"145","author":"Ng","year":"2013","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.disamonth.2017.07.001_bib17","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.3748\/wjg.v12.i23.3668","article-title":"Family and twin studies in inflammatory bowel disease","volume":"12","author":"Halme","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/gut.34.4.517","article-title":"Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews","volume":"34","author":"Yang","year":"1993","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bpg.2003.12.008","article-title":"NOD2\/CARD15: relevance in clinical practice","volume":"18","author":"Vermeire","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5804","key":"10.1016\/j.disamonth.2017.07.001_bib20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/gut.2008.163667","article-title":"Crohn\u2019s disease: th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn\u2019s disease","volume":"58","author":"Brand","year":"2009","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4065\/81.11.1462","article-title":"Smoking and Inflammatory Bowel Disease: a Meta-analysis","volume":"81","author":"Mahid","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1542-3565(03)00290-8","article-title":"Gender differences in the response of colitis to smoking","volume":"2","author":"Cosnes","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/gast.1996.v110.pm8566589","article-title":"Effects of cigarette smoking on the long-term course of Crohn\u2019s disease","volume":"110","author":"Cosnes","year":"1996","journal-title":"Gastroenterology"},{"issue":"46","key":"10.1016\/j.disamonth.2017.07.001_bib25","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.3748\/wjg.v13.i46.6134","article-title":"Smoking in inflammatory bowel diseases: good, bad or ugly?","volume":"13","author":"Lakatos","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib26","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00054725-200411000-00019","article-title":"Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications","volume":"10","author":"Birrenbach","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/ije\/22.6.1101","article-title":"Use of oral moist snuff and inflammatory bowel disease","volume":"22","author":"Persson","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.disamonth.2017.07.001_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1196\/annals.1326.003","article-title":"The intestinal microvasculature as a therapeutic target in inflammatory bowel disease","volume":"1072","author":"Hatoum","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ibd.20020","article-title":"Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis","volume":"13","author":"McGilligan","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib30","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/MIB.0000000000000129","article-title":"Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH","volume":"20","author":"Biedermann","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib31","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.07.050","article-title":"A prospective study of long-term intake of dietary fiber and risk of Crohn\u2019s disease and ulcerative colitis","volume":"145","author":"Ananthakrishnan","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mnfr.200500013","article-title":"Effects of dietary fiber on inflammatory bowel disease","volume":"49","author":"Galvez","year":"2005","journal-title":"Mol Nutr Food Res"},{"issue":"10","key":"10.1016\/j.disamonth.2017.07.001_bib33","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/gut.2009.195370","article-title":"Translocation of Crohn\u2019s disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers","volume":"59","author":"Roberts","year":"2010","journal-title":"Gut"},{"issue":"7405","key":"10.1016\/j.disamonth.2017.07.001_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ibd.20968","article-title":"Role of diet in the development of inflammatory bowel disease","volume":"16","author":"Chapman-Kiddell","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF01469792","article-title":"Increased consumption of refined carbohydrates in patients with Crohn\u2019s disease","volume":"54","author":"Martini","year":"1976","journal-title":"Klin Wochenschr"},{"issue":"6193","key":"10.1016\/j.disamonth.2017.07.001_bib37","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bmj.2.6193.762","article-title":"Diet and Crohn\u2019s disease: characteristics of the pre-illness diet","volume":"2","author":"Thornton","year":"1979","journal-title":"Br Med J"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cgh.2013.01.021","article-title":"Sleep disturbance and risk of active disease in patients with Crohn\u2019s disease and ulcerative colitis","volume":"11","author":"Ananthakrishnan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cgh.2012.08.032","article-title":"Association between depressive symptoms and incidence of Crohn\u2019s disease and ulcerative colitis: results from the Nurses\u2019 Health Study","volume":"11","author":"Ananthakrishnan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.MIB.0000161919.42878.a0","article-title":"Evidence that stress contributes to inflammatory bowel disease: evaluation, synthesis, and future directions","volume":"11","author":"Maunder","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.disamonth.2017.07.001_bib41","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/gut.2007.134817","article-title":"Predicting relapse in Crohn\u2019s disease: a biopsychosocial model","volume":"57","author":"Bitton","year":"2008","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib42","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/gut.31.9.1037","article-title":"Occupational distribution of inflammatory bowel disease among German employees","volume":"31","author":"Sonnenberg","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.disamonth.2017.07.001_bib43","first-page":"347","article-title":"Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses\u2019 Health Study cohorts","author":"Khalili","year":"2013","journal-title":"BMJ: Br Med J"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib44","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM200103153441104","article-title":"Appendectomy and protection against ulcerative colitis","volume":"344","author":"Andersson","year":"2001","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/gast.2003.50021","article-title":"Appendectomy is followed by increased risk of Crohn\u2019s disease","volume":"124","author":"Andersson","year":"2003","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib46","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1111\/j.1572-0241.2008.02118.x","article-title":"The risk of developing Crohn\u2019s disease after an appendectomy: a meta-analysis","volume":"103","author":"Kaplan","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib47","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn\u2019s disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib48","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10654-014-9922-3","article-title":"Place of upbringing in early childhood as related to inflammatory bowel diseases in adulthood: a population-based cohort study in Northern Europe","volume":"29","author":"Timm","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.crohns.2011.09.003","article-title":"Risk factors for inflammatory bowel diseases according to the \"hygiene hypothesis\": a case-control, multi-centre, prospective study in Southern Italy","volume":"6","author":"Castiglione","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"7","key":"10.1016\/j.disamonth.2017.07.001_bib51","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/gutjnl-2014-307410","article-title":"Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific","volume":"64","author":"Ng","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib52","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2004.04.061","article-title":"High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn\u2019s disease","volume":"127","author":"Darfeuille-Michaud","year":"2004","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib53","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol"},{"issue":"6052","key":"10.1016\/j.disamonth.2017.07.001_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib55","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1097\/MIB.0000000000000534","article-title":"Patterns of antibiotic exposure and clinical disease activity in inflammatory bowel disease: a 4-year prospective study","volume":"21","author":"Hashash","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib56","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/ajg.2010.398","article-title":"Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease","volume":"105","author":"Shaw","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-156-5-201203060-00007","article-title":"Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study","volume":"156","author":"Ananthakrishnan","year":"2012","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib58","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ajg.2009.15","article-title":"Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?","volume":"104","author":"Singh","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib59","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2036.2011.04784.x","article-title":"Aspirin in the aetiology of Crohn\u2019s disease and ulcerative colitis: a European prospective cohort study","volume":"34","author":"Chan","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib60","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/j.1572-0241.2008.02064.x","article-title":"The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis","volume":"103","author":"Cornish","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.disamonth.2017.07.001_bib61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2172-8-5","article-title":"Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury","volume":"8","author":"Froicu","year":"2007","journal-title":"BMC Immunol"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib62","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/jn\/130.11.2648","article-title":"1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease","volume":"130","author":"Cantorna","year":"2000","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/apt.12553","article-title":"Review article: vitamin D and inflammatory bowel diseases","volume":"39","author":"Mouli","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib64","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2011.11.040","article-title":"Higher predicted vitamin D status is associated with reduced risk of Crohn\u2019s disease","volume":"142","author":"Ananthakrishnan","year":"2012","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib65","first-page":"1921","article-title":"Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn\u2019s disease","volume":"19","author":"Ananthakrishnan","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib66","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2004.01.024","article-title":"A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn\u2019s disease","volume":"126","author":"Su","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.crohns.2009.12.003","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis","volume":"4","author":"Van Assche","year":"2010","journal-title":"J Crohn\u2019S Colitis"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib68","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cgh.2010.04.021","article-title":"Certolizumab pegol in patients with moderate to severe Crohn\u2019s disease and secondary failure to infliximab","volume":"8","author":"Sandborn","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib69","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(99)70332-X","article-title":"Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn\u2019s disease","volume":"117","author":"Rutgeerts","year":"1999","journal-title":"Gastroenterology"},{"issue":"9317","key":"10.1016\/j.disamonth.2017.07.001_bib70","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.disamonth.2017.07.001_bib71","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis","volume":"55","author":"Stange","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib72","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/MIB.0000000000000377","article-title":"Guidelines for medical treatment of Crohn\u2019s perianal fistulas: critical evaluation of therapeutic trials","volume":"21","author":"Schwartz","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib73","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","article-title":"Predictability of the postoperative course of Crohn\u2019s disease","volume":"99","author":"Rutgeerts","year":"1990","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib74","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.1994.tb00158.x","article-title":"Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn\u2019s disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)","volume":"8","author":"Caprilli","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.disamonth.2017.07.001_bib75","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/00365529509096316","article-title":"Disease activity courses in a regional cohort of Crohn\u2019s disease patients","volume":"30","author":"Munkholm","year":"1995","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ajg.2008.168","article-title":"Practice parameters committee of american college of G. management of Crohn\u2019s disease in adults","volume":"104","author":"Lichtenstein","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0016-5085(99)70549-4","article-title":"Clinical course and costs of care for Crohn\u2019s disease: markov model analysis of a population-based cohort","volume":"117","author":"Silverstein","year":"1999","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib78","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib79","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","article-title":"A simple classification of Crohn\u2019s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998","volume":"6","author":"Gasche","year":"2000","journal-title":"Inflamm Bowel Dis"},{"issue":"41","key":"10.1016\/j.disamonth.2017.07.001_bib81","doi-asserted-by":"crossref","first-page":"15374","DOI":"10.3748\/wjg.v20.i41.15374","article-title":"Performance of the Montreal classification for inflammatory bowel diseases","volume":"20","author":"Spekhorst","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib82","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/gut.49.6.777","article-title":"Behaviour of Crohn\u2019s disease according to the Vienna classification: changing pattern over the course of the disease","volume":"49","author":"Louis","year":"2001","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib83","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","article-title":"Long-term evolution of disease behavior of Crohn\u2019s disease","volume":"8","author":"Cosnes","year":"2002","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib84","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2014.09.015","article-title":"Development of the Lemann index to assess digestive tract damage in patients with Crohn\u2019s disease","volume":"148","author":"Pariente","year":"2015","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib85","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/MIB.0000000000000935","article-title":"Silent Crohn\u2019s disease predicts increased bowel damage during multiyear follow-up: the consequences of under-reporting active inflammation","volume":"22","author":"Bhattacharya","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib86","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib87","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1097\/MIB.0000000000000559","article-title":"Prevalence and risk factors for functional vitamin B12 deficiency in patients with Crohn\u2019s disease","volume":"21","author":"Ward","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00004836-198808000-00011","article-title":"The clinical significance of serum C reactive protein levels in Crohn\u2019s disease. Results of a prospective longitudinal study","volume":"10","author":"Boirivant","year":"1988","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib89","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.meg.0000131040.38607.09","article-title":"Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool","volume":"16","author":"Mylonaki","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib90","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.gtc.2009.07.003","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"38","author":"Ananthakrishnan","year":"2009","journal-title":"Gastroenterol Clin N Am"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib91","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1440-1746.2006.04764.x","article-title":"Endoscopic balloon dilatation of intestinal strictures in Crohn\u2019s disease: safe alternative to surgery","volume":"22","author":"Ajlouni","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib92","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.giec.2016.06.003","article-title":"Endoscopic evaluation and management of the postoperative Crohn\u2019s disease patient","volume":"26","author":"Hashash","year":"2016","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.disamonth.2017.07.001_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2431","article-title":"Imaging strategies for detection of urgent conditions in patients with acute abdominal pain: diagnostic accuracy study","volume":"338","author":"Lam\u00e9ris","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib94","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004728-199209000-00008","article-title":"Diagnosis of pneumoperitoneum: abdominal CT vs. upright chest film","volume":"16","author":"Stapakis","year":"1992","journal-title":"J Comput Assist Tomogr"},{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib95","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00330-006-0338-7","article-title":"Assessment of Crohn\u2019s disease in the small bowel: prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis","volume":"16","author":"Masselli","year":"2006","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.disamonth.2017.07.001_bib96","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1572-0241.2003.07521.x","article-title":"Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn\u2019s disease: a prospective comparative study","volume":"98","author":"Maconi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.disamonth.2017.07.001_bib97","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2013\/419542","article-title":"Small bowel imaging: clinical applications of the different imaging modalities \u2013 a comprehensive review","volume":"2013","author":"Masselli","year":"2013","journal-title":"ISRN Pathol"},{"issue":"27","key":"10.1016\/j.disamonth.2017.07.001_bib98","first-page":"3192","article-title":"Diagnostics in inflammatory bowel disease: ultrasound","volume":"17","author":"Strobel","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib99","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00054725-200502000-00007","article-title":"Crohn\u2019s disease: a comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema","volume":"11","author":"Calabrese","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib100","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1136\/gut.2004.041038","article-title":"Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn\u2019s disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy","volume":"53","author":"Parente","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib101","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002619900164","article-title":"Sonographic assessment of the normal and abnormal bowel wall in nondiverticular ileitis and colitis","volume":"22","author":"Pradel","year":"1997","journal-title":"Abdom Imaging"},{"issue":"10","key":"10.1016\/j.disamonth.2017.07.001_bib102","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1046\/j.1365-2036.2003.01796.x","article-title":"Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel","volume":"18","author":"Parente","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib103","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2214\/AJR.08.2027","article-title":"Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn\u2019s disease","volume":"193","author":"Siddiki","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib104","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1111\/j.1572-0241.2007.01537.x","article-title":"Correlation of CT enteroclysis with surgical pathology in Crohn\u2019s disease","volume":"102","author":"Chiorean","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejrad.2005.11.004","article-title":"Multi-detector CT-colonography in inflammatory bowel disease: prospective analysis of CT-findings to high-resolution video colonoscopy","volume":"58","author":"Andersen","year":"2006","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib106","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1522-2586(200002)11:2<127::AID-JMRI8>3.0.CO;2-G","article-title":"Crohn\u2019s disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning","volume":"11","author":"Low","year":"2000","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib107","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ibd.21534","article-title":"Interobserver and intermodality agreement for detection of small bowel Crohn\u2019s disease with MR enterography and CT enterography","volume":"17","author":"Jensen","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib108","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000320399","article-title":"MRI enterography: the future of small bowel diagnostics?","volume":"28","author":"Feuerbach","year":"2010","journal-title":"Dig Dis"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib109","doi-asserted-by":"crossref","first-page":"W375","DOI":"10.2214\/AJR.05.1079","article-title":"Hydro-MRI of the small bowel: effect of contrast volume, timing of contrast administration, and data acquisition on bowel distention","volume":"187","author":"Kuehle","year":"2006","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00261-007-9309-y","article-title":"Which method is best for imaging of perianal fistula?","volume":"33","author":"Sahni","year":"2008","journal-title":"Abdom Imaging"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib111","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/gast.2001.28676","article-title":"A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn\u2019s perianal fistulas","volume":"121","author":"Schwartz","year":"2001","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib112","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2036.2011.04710.x","article-title":"Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn\u2019s disease","volume":"34","author":"Panes","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib113","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bpg.2005.09.002","article-title":"Magnetic resonance imaging evaluation of small intestinal Crohn\u2019s disease","volume":"20","author":"Gourtsoyiannis","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib114","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/gut.2009.197665","article-title":"Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease","volume":"59","author":"Oussalah","year":"2010","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib115","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/ibd.21551","article-title":"Magnetic resonance imaging for evaluation of Crohn\u2019s disease: validation of parameters of severity and quantitative index of activity","volume":"17","author":"Rimola","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"8-9","key":"10.1016\/j.disamonth.2017.07.001_bib116","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0399-8320(05)86351-1","article-title":"Magnetic resonance imaging in Crohn\u2019s disease","volume":"29","author":"Pilleul","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib117","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2214\/ajr.177.6.1771325","article-title":"MR imaging evaluation of the activity of Crohn\u2019s disease","volume":"177","author":"Koh","year":"2001","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib118","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/gast.2002.35988","article-title":"A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease","volume":"123","author":"Costamagna","year":"2002","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.disamonth.2017.07.001_bib119","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2006.00761.x","article-title":"The risk of retention of the capsule endoscope in patients with known or suspected Crohn\u2019s disease","volume":"101","author":"Cheifetz","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.disamonth.2017.07.001_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2016.12.024","article-title":"Retention associated with video capsule endoscopy: systematic review and meta-analysis","author":"Rezapour","year":"2017","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib121","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.gie.2008.02.017","article-title":"Small-bowel imaging in Crohn\u2019s disease: a prospective, blinded, 4-way comparison trial","volume":"68","author":"Solem","year":"2008","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.disamonth.2017.07.001_bib122","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gut.30.7.983","article-title":"Development and validation of an endoscopic index of the severity for Crohn\u2019s disease: a prospective multicentre study. Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)","volume":"30","author":"Mary","year":"1989","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib123","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.crohns.2013.02.005","article-title":"Optimising monitoring in the management of Crohn\u2019s disease: a physician\u2019s perspective","volume":"7","author":"Papay","year":"2013","journal-title":"J Crohn\u2019S Colitis"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib124","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"issue":"8167","key":"10.1016\/j.disamonth.2017.07.001_bib126","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib127","first-page":"1571","article-title":"The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn\u2019s Relapse Prevention Trial","volume":"91","author":"Irvine","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"9613","key":"10.1016\/j.disamonth.2017.07.001_bib128","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","article-title":"Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn\u2019s disease: an open randomised trial","volume":"371","author":"D\u2019Haens","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib129","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/BF01314051","article-title":"Modulation of human colonic arachidonic acid metabolism by sulfasalazine","volume":"30","author":"Hawkey","year":"1985","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ajg.2011.71","article-title":"Efficacy of 5-aminosalicylates in Crohn\u2019s disease: systematic review and meta-analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib131","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.coph.2004.06.009","article-title":"The molecular complexity of glucocorticoid actions in inflammation \u2014 a four-ring circus","volume":"4","author":"Goulding","year":"2004","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib132","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2036.2003.01386.x","article-title":"Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn\u2019s disease","volume":"17","author":"Lundin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib133","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ajg.2011.70","article-title":"Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib134","first-page":"CD000545","article-title":"Azathioprine or 6-mercaptopurine for induction of remission in Crohn\u2019s disease","author":"Chande","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ajg.2011.64","article-title":"Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib136","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1038\/ajg.2009.301","article-title":"Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn\u2019s disease: a meta-analysis","volume":"104","author":"Peyrin-Biroulet","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib137","first-page":"CD000067","article-title":"Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn\u2019s disease","author":"Prefontaine","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib138","first-page":"CD000545","article-title":"Azathioprine or 6-mercaptopurine for induction of remission in Crohn\u2019s disease","author":"Prefontaine","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"8996","key":"10.1016\/j.disamonth.2017.07.001_bib139","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(96)90402-X","article-title":"Long-term follow-up of patients with Crohn\u2019s disease treated with azathioprine or 6-mercaptopurine","volume":"347","author":"Bouhnik","year":"1996","journal-title":"Lancet"},{"issue":"9701","key":"10.1016\/j.disamonth.2017.07.001_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"1617","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib141","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2010.09.016","article-title":"A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease","volume":"9","author":"Kotlyar","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib142","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease","volume":"141","author":"Peyrin-Biroulet","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib143","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation","volume":"92","author":"Cronstein","year":"1993","journal-title":"J Clin Investig"},{"issue":"22","key":"10.1016\/j.disamonth.2017.07.001_bib144","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohn\u2019s disease. North American Crohn\u2019s Study Group Investigators","volume":"342","author":"Feagan","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn\u2019s disease. The North American Crohn\u2019s Study Group Investigators","volume":"332","author":"Feagan","year":"1995","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.disamonth.2017.07.001_bib146","first-page":"1724","article-title":"Methotrexate in Crohn\u2019s disease: results of a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Arora","year":"1999","journal-title":"Hepatogastroenterology"},{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib147","first-page":"2203","article-title":"Methotrexate in chronic active Crohn\u2019s disease: a double-blind, randomized, Israeli multicenter trial","volume":"92","author":"Oren","year":"1997","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib148","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/j.1572-0241.2000.03287.x","article-title":"Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease","volume":"95","author":"Te","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib149","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1060028016672035","article-title":"Interaction between low-dose methotrexate and nonsteroidal anti-inflammatory drugs, penicillins, and proton pump inhibitors","volume":"51","author":"Hall","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib150","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ecco-jcc\/jjv096","article-title":"Infliximab-Related Infusion Reactions: systematic Review","volume":"9","author":"Lichtenstein","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib151","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa067594","article-title":"Certolizumab pegol for the treatment of Crohn\u2019s disease","volume":"357","author":"Sandborn","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib152","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MAJ.0b013e31822b7bb8","article-title":"Neurological deficits during treatment with tumor necrosis factor-alpha antagonists","volume":"342","author":"Nozaki","year":"2011","journal-title":"Am J Med Sci"},{"issue":"15","key":"10.1016\/j.disamonth.2017.07.001_bib153","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"issue":"Pt 19","key":"10.1016\/j.disamonth.2017.07.001_bib154","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1242\/jcs.03098","article-title":"Integrin ligands at a glance","volume":"119","author":"Humphries","year":"2006","journal-title":"J Cell Sci"},{"issue":"18","key":"10.1016\/j.disamonth.2017.07.001_bib155","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJMoa043335","article-title":"Natalizumab induction and maintenance therapy for Crohn\u2019s disease","volume":"353","author":"Sandborn","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib156","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2007.03.024","article-title":"Natalizumab for the treatment of active Crohn\u2019s disease: results of the ENCORE trial","volume":"132","author":"Targan","year":"2007","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib157","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib158","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/apt.12639","article-title":"Review article: anti-adhesion therapies for inflammatory bowel disease","volume":"39","author":"Lobaton","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib159","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/ene.12988","article-title":"High cumulative JC virus seroconversion rate during long-term use of natalizumab","volume":"23","author":"Vennegoor","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.disamonth.2017.07.001_bib160","article-title":"The safety of vedolizumab for ulcerative colitis and Crohn\u2019s disease","author":"Colombel","year":"2016","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.disamonth.2017.07.001_bib161","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199409293311303","article-title":"Oral budesonide for active Crohn\u2019s disease. Canadian Inflammatory Bowel Disease Study Group","volume":"331","author":"Greenberg","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib162","first-page":"CD000296","article-title":"Budesonide for induction of remission in Crohn\u2019s disease","author":"Seow","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"10.1016\/j.disamonth.2017.07.001_bib163","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJM199409293311304","article-title":"A comparison of budesonide with prednisolone for active Crohn\u2019s disease","volume":"331","author":"Rutgeerts","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib164","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ajg.2008.168","article-title":"Management of Crohn\u2019s disease in adults","volume":"104","author":"Lichtenstein","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1542-3565(04)00122-3","article-title":"Oral Pentasa in the treatment of active Crohn\u2019s disease: a meta-analysis of double-blind, placebo-controlled trials","volume":"2","author":"Hanauer","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib166","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: current management","volume":"4","author":"Dignass","year":"2010","journal-title":"J Crohn\u2019S Colitis"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib167","first-page":"CD006792","article-title":"Traditional corticosteroids for induction of remission in Crohn\u2019s disease","author":"Benchimol","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib168","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/gut.41.2.209","article-title":"Oral budesonide is as effective as oral prednisolone in active Crohn\u2019s disease. The Global Budesonide Study Group","volume":"41","author":"Campieri","year":"1997","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib169","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90002-I","article-title":"Clinical, biological, and endoscopic picture of attacks of Crohn\u2019s disease. Evolution on prednisolone. Groupe d\u2019Etude Therapeutique des Affections Inflammatoires Digestives","volume":"98","author":"Modigliani","year":"1990","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0016-5085(84)90409-8","article-title":"European Cooperative Crohn\u2019s Disease Study (ECCDS): results of drug treatment","volume":"86","author":"Malchow","year":"1984","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib171","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.35.3.360","article-title":"Frequency of glucocorticoid resistance and dependency in Crohn\u2019s disease","volume":"35","author":"Munkholm","year":"1994","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib172","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib173","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2013.10.046","article-title":"American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-alpha biologic drugs for the induction and maintenance of remission in inflammatory Crohn\u2019s disease","volume":"145","author":"Dassopoulos","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib174","article-title":"Azathioprine or 6-mercaptopurine for inducing remission of Crohn\u2019s disease","author":"Sandborn","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib175","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1053\/j.gastro.2006.01.048","article-title":"American Gastroenterological A. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.disamonth.2017.07.001_bib176","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: current management","volume":"55","author":"Travis","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib177","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/j.gastro.2006.02.014","article-title":"Infliximab plus azathioprine for steroid-dependent Crohn\u2019s disease patients: a randomized placebo-controlled trial","volume":"130","author":"Lemann","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib178","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2004.02.070","article-title":"Optimizing anti-TNF treatment in inflammatory bowel disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib179","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","article-title":"Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial","volume":"146","author":"Sandborn","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn\u2019s disease: the CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib181","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib182","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn\u2019s disease: results of the CLASSIC II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib183","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.gastro.2005.06.064","article-title":"A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn\u2019s disease","volume":"129","author":"Schreiber","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib184","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11938-007-0013-3","article-title":"Current and future anti-TNF therapy for inflammatory bowel disease","volume":"10","author":"Osterman","year":"2007","journal-title":"Curr Treat Opt Gastroenterol"},{"key":"10.1016\/j.disamonth.2017.07.001_bib185","doi-asserted-by":"crossref","unstructured":"Avasarala J. The TOUCH program and natalizumab: Fundamental flaw in patient protection. F1000Res. 2015;4:1450.","DOI":"10.12688\/f1000research.7513.3"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib186","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib187","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1053\/j.gastro.2014.05.008","article-title":"Effects of vedolizumab induction therapy for patients with crohn\u2019s disease in whom tumor necrosis factor antagonist treatment failed","volume":"147","author":"Sands","year":"2014","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib188","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/MIB.0b013e318281f538","article-title":"Long-term clinical experience with vedolizumab in patients with inflammatory bowel disease","volume":"19","author":"Parikh","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.disamonth.2017.07.001_bib189","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/gast.2002.33632","article-title":"Mortality and causes of death in Crohn\u2019s disease: follow-up of a population-based cohort in Copenhagen County, Denmark","volume":"122","author":"Jess","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00054725-200303000-00008","article-title":"Gastroduodenal Crohn\u2019s disease: medical management","volume":"9","author":"Tremaine","year":"2003","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.disamonth.2017.07.001_bib191","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00042737-199810000-00001","article-title":"Clinical pattern of corticosteroid dependent Crohn\u2019s disease","volume":"10","author":"Franchimont","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib192","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1572-0241.2005.41992.x","article-title":"Budesonide for maintenance of remission in patients with Crohn\u2019s disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials","volume":"100","author":"Sandborn","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib193","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0016-5085(97)70117-3","article-title":"A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn\u2019s disease. The Canadian Mesalamine for Remission of Crohn\u2019s Disease Study Group","volume":"112","author":"Sutherland","year":"1997","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib194","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn\u2019s disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa062897","article-title":"Maintenance therapy with certolizumab pegol for Crohn\u2019s disease","volume":"357","author":"Schreiber","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib196","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1053\/j.gastro.2005.12.019","article-title":"Predictors of Crohn\u2019s disease","volume":"130","author":"Beaugerie","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.disamonth.2017.07.001_bib197","unstructured":"Seksik P, Loftus EV, Beaugerre L, Harmsen WS, Zinsmeister AR, Cosnes J., et al., editors. Validation of predictors of 5-year disabling CD in a population based cohort from Olmsted county, Minnesota, 1983\u20131996. Gastroenterology: WBSAUNDERS CO-ELSEVIER INC 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA; 2007."},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib198","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/00365520801957149","article-title":"Predictors of severe Crohn\u2019s disease","volume":"43","author":"Loly","year":"2008","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1016\/j.disamonth.2017.07.001_bib199","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00464-005-0500-3","article-title":"Comparison of laparoscopic and open ileocecal resection for Crohn\u2019s disease: a metaanalysis","volume":"20","author":"Tilney","year":"2006","journal-title":"Surg Endosc Other Interv Tech"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10620-015-3895-2","article-title":"Analysis of hospital-based emergency department visits for inflammatory bowel disease in the USA","volume":"61","author":"Gajendran","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib201","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0016-5085(03)00883-7","article-title":"Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients","volume":"125","author":"Aberra","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004836-200105000-00010","article-title":"Abscesses in Crohn\u2019s disease: outcome of medical versus surgical treatment","volume":"32","author":"Garcia","year":"2001","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib203","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00535-003-1317-2","article-title":"The clinical characteristics and outcome of intraabdominal abscess in Crohn\u2019s disease","volume":"39","author":"Yamaguchi","year":"2004","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib204","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.gastro.2016.10.039","article-title":"American gastroenterological association institute technical review on the management of Crohn\u2019s disease after surgical resection","volume":"152","author":"Regueiro","year":"2017","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib205","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/ajg.2014.297","article-title":"Cumulative incidence of second intestinal resection in Crohn\u2019s disease: a systematic review and meta-analysis of population-based studies","volume":"109","author":"Frolkis","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(12)61008-7","article-title":"Patterns of clinical recurrence and health care utilization in post-operative Crohn\u2019s disease: two year outcomes","volume":"142","author":"Gajendran","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib207","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2036.2008.03774.x","article-title":"Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn\u2019s disease","volume":"28","author":"Pascua","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.disamonth.2017.07.001_bib208","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/ibd.20909","article-title":"Management and prevention of postoperative Crohn\u2019s disease","volume":"15","author":"Regueiro","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib209","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000658-193811000-00007","article-title":"Perianal Fistulae as a Complication of Regional Ileitis","volume":"108","author":"Penner","year":"1938","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib210","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/gut.21.6.525","article-title":"Occurrence and outcome after primary treatment of anal fistulae in Crohn\u2019s disease","volume":"21","author":"Hellers","year":"1980","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib211","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2036.2003.01561.x","article-title":"The clinical course of fistulating Crohn\u2019s disease","volume":"17","author":"Bell","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib212","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0009-9260(05)82906-X","article-title":"Magnetic resonance imaging of fistula-in-ano: technique, interpretation and accuracy","volume":"49","author":"Barker","year":"1994","journal-title":"Clin Radiol"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib213","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2214\/ajr.152.5.999","article-title":"Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging","volume":"152","author":"Koelbel","year":"1989","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib214","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1052-5157(02)00013-2","article-title":"The role of endoscopy in the evaluation of fistulizing Crohn\u2019s disease","volume":"12","author":"Regueiro","year":"2002","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00054725-200303000-00003","article-title":"Treatment of perianal fistulizing Crohn\u2019s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement","volume":"9","author":"Regueiro","year":"2003","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib216","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","article-title":"Usual therapy improves perianal Crohn\u2019s disease as measured by a new disease activity index. McMaster IBD Study Group","volume":"20","author":"Irvine","year":"1995","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib217","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","article-title":"Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn\u2019s disease","volume":"98","author":"Van Assche","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib218","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0016-5085(80)90155-9","article-title":"Healing of perineal Crohn\u2019s disease with metronidazole","volume":"79","author":"Bernstein","year":"1980","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.disamonth.2017.07.001_bib219","first-page":"533","article-title":"Metronidazole therapy for Crohn\u2019s disease and associated fistulae","volume":"79","author":"Jakobovits","year":"1984","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"10.1016\/j.disamonth.2017.07.001_bib220","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.disamonth.2017.07.001_bib221","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S1542-3565(04)00414-8","article-title":"Long-term treatment of rectovaginal fistulas in Crohn\u2019s disease: response to infliximab in the ACCENT II Study","volume":"2","author":"Sands","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib222","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/apt.12478","article-title":"Systematic review: fertility in non-surgically treated inflammatory bowel disease","volume":"38","author":"Tavernier","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib223","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00384-011-1274-9","article-title":"Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review","volume":"26","author":"Rajaratnam","year":"2011","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib224","first-page":"96","article-title":"Pregnancy and inflammatory bowel disease","volume":"11","author":"Hashash","year":"2015","journal-title":"Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib225","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.2006.108324","article-title":"A meta-analysis on the influence of inflammatory bowel disease on pregnancy","volume":"56","author":"Cornish","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib226","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The toronto consensus statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib227","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second european evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease","volume":"9","author":"van der Woude","year":"2015","journal-title":"J Crohn\u2019S Colitis"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib228","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/DCR.0b013e3182a41381","article-title":"Crohn\u2019s disease and pregnancy: the impact of perianal disease on delivery methods and complications","volume":"57","author":"Hatch","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib229","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1572-0241.2007.01756.x","article-title":"Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes","volume":"103","author":"Reddy","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 2","key":"10.1016\/j.disamonth.2017.07.001_bib230","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"Thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.disamonth.2017.07.001_bib231","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-med-012309-103958","article-title":"The brain-gut axis in abdominal pain syndromes","volume":"62","author":"Mayer","year":"2011","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib232","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1152\/jn.1998.80.5.2632","article-title":"Mechanosensitive pelvic nerve afferent fibers innervating the colon of the rat are polymodal in character","volume":"80","author":"Su","year":"1998","journal-title":"J Neurophysiol"},{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib233","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1097\/MIB.0000000000000170","article-title":"Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside","volume":"20","author":"Srinath","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib234","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/SPC.0b013e32834f6ec9","article-title":"Visceral pain: the ins and outs, the ups and downs","volume":"6","author":"Sikandar","year":"2012","journal-title":"Curr Opin Support Palliat Care"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib235","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1097\/MIB.0000000000000921","article-title":"IBS-like symptoms in patients with ulcerative colitis in deep remission are associated with increased levels of serum cytokines and poor psychological well-being","volume":"22","author":"Jonefjall","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib236","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/ajg.2010.162","article-title":"Inflammatory bowel disease, irritable bowel syndrome, or what?: a challenge to the functional-organic dichotomy","volume":"105","author":"Long","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib237","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/ajg.2010.156","article-title":"Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?","volume":"105","author":"Keohane","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.disamonth.2017.07.001_bib238","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ajg.2012.260","article-title":"Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis","volume":"107","author":"Halpin","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib239","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","article-title":"Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases","volume":"22","author":"Mikocka-Walus","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.disamonth.2017.07.001_bib240","first-page":"111","article-title":"Inflammatory bowel disease and anxiety: links, risks, and challenges faced","volume":"8","author":"Bannaga","year":"2015","journal-title":"Clin Exp Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib241","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.PSY.0000106907.24881.F2","article-title":"Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study","volume":"66","author":"Mittermaier","year":"2004","journal-title":"Psychosom Med"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib242","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cgh.2015.12.045","article-title":"Swiss IBDCSG. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease","volume":"14","author":"Mikocka-Walus","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.disamonth.2017.07.001_bib243","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1440-1746.2006.04820.x","article-title":"Impact of sleep disturbances in inflammatory bowel disease","volume":"22","author":"Ranjbaran","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.disamonth.2017.07.001_bib244","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.crohns.2013.02.004","article-title":"Psychotherapy for inflammatory bowel disease: a review and update","volume":"7","author":"McCombie","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib245","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/00029157.2015.1040112","article-title":"Hypnotherapy for inflammatory bowel disease across the lifespan","volume":"58","author":"Szigethy","year":"2015","journal-title":"Am J Clin Hypn"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib246","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/MIB.0000000000000734","article-title":"Empirically supported use of psychiatric medications in adolescents and adults with IBD","volume":"22","author":"Thorkelson","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib247","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpsychores.2014.12.009","article-title":"Identifying effective techniques within psychological treatments for irritable bowel syndrome: a meta-analysis","volume":"78","author":"Henrich","year":"2015","journal-title":"J Psychosom Res"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib248","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.crohns.2014.01.018","article-title":"Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels","volume":"8","author":"Berrill","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib249","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1037\/a0035747","article-title":"Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research","volume":"69","author":"Ehde","year":"2014","journal-title":"Am Psychol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib250","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cgh.2012.10.031","article-title":"Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist","volume":"11","author":"Palsson","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib251","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2016.10.036","article-title":"Etiology and treatment of pain and psychosocial issues in patients with inflammatory bowel diseases","volume":"152","author":"Regueiro","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.disamonth.2017.07.001_bib252","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib253","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/ALN.0000000000000170","article-title":"Buprenorphine\u2013naloxone therapy in pain management","volume":"120","author":"Chen","year":"2014","journal-title":"Anesthesiology"},{"issue":"7","key":"10.1016\/j.disamonth.2017.07.001_bib254","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrgastro.2014.53","article-title":"Diagnosis and treatment of narcotic bowel syndrome","volume":"11","author":"Kurlander","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib255","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2008.163162","article-title":"Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis","volume":"58","author":"Ford","year":"2009","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.disamonth.2017.07.001_bib256","first-page":"592","article-title":"Managing pain in inflammatory bowel disease","volume":"7","author":"Docherty","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.disamonth.2017.07.001_bib257","doi-asserted-by":"crossref","first-page":"Suppl:S89","DOI":"10.1097\/MCG.0b013e31821fbd82","article-title":"Understanding and treating abdominal pain and spasms in organic gastrointestinal diseases: inflammatory bowel disease and biliary diseases","volume":"45","author":"Makharia","year":"2011","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.disamonth.2017.07.001_bib258","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib259","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/M14-2841","article-title":"Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis","volume":"163","author":"Trauer","year":"2015","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib260","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.anclin.2016.01.007","article-title":"Assessing and managing sleep disturbance in patients with chronic pain","volume":"34","author":"Cheatle","year":"2016","journal-title":"Anesthesiol Clin"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib261","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5152\/tjg.2014.4955","article-title":"Effects of enteral nutritional support on malnourished patients with inflammatory bowel disease by subjective global assessment","volume":"25","author":"S\u00f6k\u00fclmez","year":"2014","journal-title":"Turk J Gastroenterol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib262","first-page":"575","article-title":"Restriction of dairy products; a reality in inflammatory bowel disease patients","volume":"29","author":"Brasil Lopes","year":"2014","journal-title":"Nutr Hosp"},{"issue":"1","key":"10.1016\/j.disamonth.2017.07.001_bib263","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S0029665114001621","article-title":"Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?","volume":"74","author":"O\u2019Sullivan","year":"2015","journal-title":"Proc Nutr Soc"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib264","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/0148607114566656","article-title":"Self-screening for malnutrition risk in outpatient inflammatory bowel disease patients using the Malnutrition Universal Screening Tool (MUST)","volume":"40","author":"Sandhu","year":"2016","journal-title":"JPEN J Parenter Enter Nutr"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0884533608318674","article-title":"Is there a role for bowel rest in nutrition management of Crohn\u2019s disease?","volume":"23","author":"Wiese","year":"2008","journal-title":"Nutr Clin Pract"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib266","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3748\/wjg.v21.i4.1299","article-title":"Impact of enteral nutrition on energy metabolism in patients with Crohn\u2019s disease","volume":"21","author":"Zhao","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.07.001_bib267","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2036.2009.04035.x","article-title":"Review article: diet and inflammatory bowel disease--epidemiology and treatment","volume":"30","author":"Yamamoto","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.disamonth.2017.07.001_bib268","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MEG.0b013e3280bdc1fc","article-title":"Novel substrates","volume":"19","author":"Wahed","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"21","key":"10.1016\/j.disamonth.2017.07.001_bib269","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3748\/wjg.15.2570","article-title":"Nutritional status and nutritional therapy in inflammatory bowel diseases","volume":"15","author":"Hartman","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.disamonth.2017.07.001_bib270","doi-asserted-by":"crossref","first-page":"197167","DOI":"10.1155\/2015\/197167","article-title":"The role of enteral nutrition in patients with inflammatory bowel disease: current aspects","volume":"2015","author":"Triantafillidis","year":"2015","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib271","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2036.2003.01482.x","article-title":"Review article: nutrition and adult inflammatory bowel disease","volume":"17","author":"Goh","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.disamonth.2017.07.001_bib272","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ibd.20429","article-title":"Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients","volume":"14","author":"Nguyen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.disamonth.2017.07.001_bib273","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ecco-jcc\/jjv051","article-title":"Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn\u2019s disease-considerations in pre-operative and peri-operative optimisation techniques to improve outcome","volume":"9","author":"Morar","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib274","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archsurg.2010.40","article-title":"Risk factors for anastomotic leak following colorectal surgery: a case-control study","volume":"145","author":"Telem","year":"2010","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.disamonth.2017.07.001_bib275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/ecco-jcc\/jju028","article-title":"Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn\u2019s disease: a meta-analysis of observational studies","volume":"9","author":"Huang","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.disamonth.2017.07.001_bib276","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ejcn.2014.16","article-title":"Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn\u2019s disease","volume":"68","author":"Li","year":"2014","journal-title":"Eur J Clin Nutr"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502917301530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502917301530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T11:47:22Z","timestamp":1570016842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502917301530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":276,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0011502917301530"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2017.07.001","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review and update on Crohn's disease","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}